JCOClass II
Bothrops Atrox Reagent
21 CFR 864.8100 / Hematology
JCO is the FDA product code for Bothrops Atrox Reagent, a class II device type, regulated under 21 CFR 864.8100. As of , FDA records hold 7 510(k) clearances under this code, the most recent dated , and no recalls.
Classification record
- Product code
- JCO
- Device name
- Bothrops Atrox Reagent
- Regulation
- 21 CFR 864.8100
- Device class
- Class II
- Review panel
- Hematology
- Submission type
- 510(k)
- Implant
- No
- Life sustaining or supporting
- No
- GMP exempt
- No
- Third party review eligible
- Yes
- Ingested clearances
- 7
- Ingested recalls
- 0
Clearances, product code JCO
By decision yearShow the numbers
| Year | Clearances |
|---|---|
| 1978 | 1 |
| 1984 | 2 |
| 1985 | 1 |
| 1989 | 1 |
| 1993 | 1 |
| 1996 | 1 |
Applicants with the most clearances
Product code JCO| Applicant | Clearances |
|---|---|
| Medical Diagnostic Technologies, Inc. | 2 |
| Behring Diagnostics, Inc. | 1 |
| Bio/Data Corp. | 1 |
| E.I. Dupont de Nemours & Co., Inc. | 1 |
| Sigma Chemical Co. | 1 |
| Wellcome Diagnostics | 1 |
Companies listing this code with FDA
Companies whose registered establishments list this codeFIRST ARTICLE / WEEKLY
What cleared, what was recalled, and what changed in the standards. One edition a week for the people who make medical devices.
